Antiretroviral choice and severe disease predict poorer neuropsychological outcomes in HIV+ children from Africa

Antiretroviral choice and severe disease predict poorer neuropsychological outcomes in HIV+ children from Africa

BackgroundThe International Maternal Pediatric Adolescent AIDS Clinical Trials Network (IMPAACT) P1104s study evaluated neuropsychological outcomes over 96 weeks in children living with HIV (CLHIV) aged 5–11 years at 6 Sub-Saharan African sites to explore associations between HIV-illness related bio...

Full description

Bibliographic Details
Main Authors: Lee Fairlie, Miriam Chernoff, Mark F. Cotton, Mutsa Bwakura-Dangarembizi, Avy Violari, Itziar Familiar-Lopez, Linda Barlow-Mosha, Portia Kamthunzi, Katie McCarthy, Patrick Jean-Philippe, Barbara Laughton, Paul E. Palumbo, Michael J. Boivin
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Pediatrics
Subjects:
pediatric HIV
antiretrovirals
neuropsychological outcomes
disease severity
predictors
Online Access:https://www.frontiersin.org/articles/10.3389/fped.2022.899002/full

Internet

https://www.frontiersin.org/articles/10.3389/fped.2022.899002/full

Similar Items